SEC Filing Timeline
8-KSep 08, 2026
Reg FD disclosure · Items 7.01,8.01,9.01
DEFA14AAug 14, 2026
Additional proxy
10-QAug 06, 2026
Quarterly report
8-KAug 06, 2026
Earnings release · Items 2.02,9.01
DEFA14AJul 30, 2026
Additional proxy
DEF 14AJul 30, 2026
Proxy statement
8-KJul 13, 2026
Other material event · Items 8.01,9.01
8-KJun 11, 2026
Other material event · Items 5.07,8.01
8-KJun 03, 2026
Executive officer change · Items 5.02
8-KMay 14, 2026
Executive officer change · Items 5.02,8.01
8-KMay 14, 2026
Unregistered share issuance · Items 2.03,3.02,7.01,9.01
10-QMay 08, 2026
Quarterly report
8-KMay 07, 2026
Unregistered share issuance · Items 1.01,1.02,2.02,2.03,3.02,9.01
8-KMay 05, 2026
Earnings release · Items 2.02,8.01,9.01
8-KMay 04, 2026
Earnings release · Items 2.02,7.01,8.01,9.01
Recent News (Finnhub)
Ocugen Targets Three Gene Therapy BLA Filings as Retinal Pipeline Advances
Ocugen: Q3 Data Catalyst In Stargardt Disease Feels Critical
Ocugen: My Hold Rating Continued On OCU410ST Advancement And Upcoming Catalysts
What's Happening With Ocugen Stock Thursday?
HC Wainwright & Co. Maintains Buy on Ocugen, Lowers Price Target to $9.5
12 Health Care Stocks Moving In Wednesday's After-Market Session
12 Health Care Stocks Moving In Wednesday's Intraday Session